Intelligence Platform
Patents
Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6172061
Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative
expired patentUS 6172086
Methods and compositions for stimulating neurite growth
expired patentUS 6172089
Pharmaceutical composition
expired patentUS 6171856
Methods and compositions relating to no-mediated cytotoxicity
expired patentUS 6169074
Peptide inhibitors of neurotransmitter secretion by neuronal cells
expired patentUS 6167888
Method for inducing partial recovery of lost voluntary motor function after spinal cord in
expired patentUS 6169068
Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives
expired patentUS 6169099
Pharmaceutical composition
expired patentUS 6169100
Pharmaceutical composition
expired patentUS 6166079
DFMO for the treatment or prevention of cervical intraepithelial neoplasia
expired patentUS 6166043
Pharmaceutical composition
expired patentUS 6165745
Recombinant production of immunoglobulin-like domains in prokaryotic cells
expired patentUS 6165738
Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylas
expired patentUS 6166042
Pharmaceutical composition
expired patentUS 6165484
EDTA and other chelators with or without antifungal antimicrobial agents for the preventio
expired patentUS 6165460
Generation of immune responses to prostate-specific antigen (PSA)
expired patentUS 6165440
Radiation and nanoparticles for enhancement of drug delivery in solid tumors
expired patentUS 6165781
Modified adeno-associated virus vector capable of expression from a novel promoter
expired patentUS 6165794
Suppression of proteolytic activity by dysfunctional protease formation
expired patentUS 6162445
Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
expired patentUS 6162815
RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising
expired patentUS 6162787
Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, an
expired patentUS 6162620
Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines,
expired patentUS 6162432
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using
expired